Partnering with Athletes to Assess Risk of COVID-Related Myocarditis
Partnering with Athletes to Assess Risk of COVID-Related Myocarditis
Abstract BackgroundMyocarditis in athletes is a feared complication of SARS-CoV-2, yet guidelines for screening with cardiac magnetic resonance imaging are lacking. Further, stakeholder involvement in the research is rare. HypothesisWe sought to determine the rates of cardiac magnetic resonance imaging evidence of SARS-CoV-2 related myocarditis in student athletes. We hypothesized that rates of myocarditis were lower than initially reported and that including athletes on the research team would enhance participant satisfaction and scientific integrity. MethodsAccordingly, when members of a hockey team were infected with SARS-CoV-2, we invited them and their team physicians to be part of the design of a study assessing the incidence of myocarditis. We performed cardiac magnetic resonance imaging on participating hockey players infected with SARS-CoV-2 and compared them to a healthy lacrosse cohort. Participants were given an optional survey to complete at the end of the study to assess their satisfaction with it. ResultsFour hockey players and two team physicians joined the study team; eight hockey players and four lacrosse players participated in the study. Zero athletes met imaging criteria for myocarditis; delayed enhancement was observed in seven cases and three controls. Athletes supported sharing the findings with the participants. No athletes reported feeling uncomfortable participating, knowing other athletes participated on the research team. ConclusionRates of SARS-CoV-2 myocarditis in young athletes appears to be lower than initially reported. Partnered research is important, especially in populations with more to lose, such as collegiate athletes; future studies should include stakeholders in the study design and execution. Key pointsCardiac MRI findings of myocarditis after COVID infection in young athletes is rare. Subjects of research studies appreciate involvement in the development of the study, and this also builds trust with the research team.
Lampert Rachel、Lynch Matthew、McNamara Robert、Miller Edward J.、Spatz Erica S.、Welsh Tyler、Johnson Kyle、Young Lawrence H.、Feher Attila、Baldassarre Lauren A.、Kay Bradley、Arlis-Mayor Stephanie、Lamy Jerome、Wagner Henry、Kemp Phil、Reinhardt Samuel、Mojibian Hamid、Peters Dana、Cuomo Jason
Section of Cardiovascular Medicine, Yale School of MedicineSection of Internal Medicine, Yale School of MedicineSection of Cardiovascular Medicine, Yale School of MedicineSection of Cardiovascular Medicine, Yale School of MedicineSection of Cardiovascular Medicine, Yale School of MedicineYale UniversityYale UniversitySection of Cardiovascular Medicine, Yale School of MedicineSection of Cardiovascular Medicine, Yale School of MedicineSection of Cardiovascular Medicine, Yale School of Medicine||Department of Radioloy and Biomedical Imaging, Yale School of MedicineSection of Cardiovascular Medicine, Yale School of MedicineSection of Internal Medicine, Yale School of MedicineDepartment of Radioloy and Biomedical Imaging, Yale School of MedicineYale UniversityYale UniversitySection of Cardiovascular Medicine, Yale School of MedicineDepartment of Radioloy and Biomedical Imaging, Yale School of MedicineDepartment of Radioloy and Biomedical Imaging, Yale School of MedicineSection of Cardiovascular Medicine, Yale School of Medicine
医学研究方法医药卫生理论预防医学
Lampert Rachel,Lynch Matthew,McNamara Robert,Miller Edward J.,Spatz Erica S.,Welsh Tyler,Johnson Kyle,Young Lawrence H.,Feher Attila,Baldassarre Lauren A.,Kay Bradley,Arlis-Mayor Stephanie,Lamy Jerome,Wagner Henry,Kemp Phil,Reinhardt Samuel,Mojibian Hamid,Peters Dana,Cuomo Jason.Partnering with Athletes to Assess Risk of COVID-Related Myocarditis[EB/OL].(2025-03-28)[2025-04-28].https://www.medrxiv.org/content/10.1101/2022.01.29.22270074.点此复制
评论